Cite
HARVARD Citation
Yamazaki, N. et al. (n.d.). 520 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538/BMS-936558) in Japanese patients with advanced melanoma: Preliminary report. European journal of cancer. pp. S110-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamazaki, N. et al. (n.d.). 520 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538/BMS-936558) in Japanese patients with advanced melanoma: Preliminary report. European journal of cancer. pp. S110-. [Online].